Posts Tagged ‘Precision Medicine’

  As many of you know, Perficient has a practice devoted to Salesforce.com solutions. So, it shouldn’t be a surprise that a bunch of my colleagues are at this year’s Dreamforce event and furiously blogging about what they’re hearing. One of the posts that caught my attention was from Mike Porter, who sat in Dr. […]

  While pharmaceutical companies are still trying to figure out whether they should partner with companion diagnostic makers, acquire them, or simply begin developing their own tests, one thing remains certain: companion diagnostics are here to stay. 

  Since President Obama’s State of the Union address in January, much has been said about precision medicine. And, rightly so. The ability to treat common and rare diseases based on genomic and patient data is showing incredible promise. However, the medical community agrees that significant changes need to be made to federal healthcare policies […]

<   The work we’re doing for life sciences and healthcare companies continues to pay off. And, Oracle thinks so, too. We recently received an award from Oracle’s Health Sciences Global Business Unit for the work we’re doing with their clinical and pharmacovigilance applications. 

  In a recent interview with Penn Medicine’s associate vice president of health technology and academic computing, Brian Wells, and chief data scientist, Michael Draugelis, Healthcare Informatics’ David Raths was able to glean great insight into how the organization is leveraging IT to support their patient care, clinical trials, and precision medicine efforts. 

  Dr. Janet Woodcock, the director of the Center for Drug Evaluation and Research (CDER) at the FDA, recently posted a blog piece that discussed the department’s strides in precision and personalized medicine. She points out that since 2012, CDER has approved 30 targeted therapies, eight of which were in 2014. 

  Launched with a $215 million investment in the President Obama’s 2016 Budget, the Precision Medicine Initiative will pioneer a new model of patient-powered research that promises to accelerate biomedical discoveries and provide clinicians with new tools, knowledge, and therapies to select the treatments that will work best for their patients. 

  Soon after I published a post on the mention of precision medicine in President Barack Obama’s January 28, 2015 State of the Union address, The White House released additional information on their initiative. The President’s 2016 Budget is set to allocate $215 million to the National Institutes of Health (NIH), Food and Drug Administration […]

OK, maybe that’s an overstatement. But, it’s worth mentioning that President Barack Obama briefly talked about “precision medicine” in his State of the Union address last week. Here’s what he had to say: Twenty-first century businesses will rely on American science and technology, research and development. I want the country that eliminated polio and mapped […]

I recently heard a segment on the radio about personalized medicine. Or “translational medicine.” Or “translational research.” Or “precision medicine.” Whatever you want to call it! Dr. Murray Feingold, a pediatrician and geneticist in the Boston area, painted a clear description of the term. He put it in words that all of us can understand. […]

While big data is a catchy buzzword and many race to offer their own definition of it, many still struggle to understand what it really means and question its real value. According to a recent survey conducted by Talend, only 10% of respondents were engaged in a large scale big data implementation project, while 36% […]

The success of translational medicine is in the data and the ability to combine multiple sources of data to enable better patient care and outcomes. Unfortunately most academic research organizations (ARO) and hospitals have multiple systems that house data creating an inability to mine through the data to identify clinical insights, disease patterns or treatment […]